1. Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis. (8th October 2016) Authors: Trauner, M.; Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S.; Bowlus, C.; Invernizzi, P.; Drenth, J.; Pockros, P.; Regula, J.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; van Erpecum, K.; Vargas, V.; Vincent, C.; Hansen, B.; MacConell, L.; Marmon, T. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.01.4 THREE YEARS OF OBETICHOLIC ACID (OCA) THERAPY RESULTS IN HISTOLOGICAL IMPROVEMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: FURTHER ANALYSIS OF THE POISE BIOPSY SUBSTUDY. (25th March 2019) Authors: Bowlus, C.L.; Pockros, P.; Kremer, A.; Pares, A.; Forman, L.M.; Drenth, J.P.; Ryder, S.; Floreani, A.; Terracciano, L.; Jin, Y.; Lieberman, A.; Pencheck, R.; Iloeje, U.; Macconell, L.; Bedossa, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗